GIL: The Market Does Not Get It (Though CEO Does).

04/28/08 10:27AM EDT
Chamandy sold $147mm in stock in 4Q, just as a multi-year run in margin improvement from accelerated sales growth layered on top of sourcing-driven cost cuts showed signs of cooling. 4 of the top 8 buyers of the stock were Canadian. Average multiple of 22x EBITDA was seemingly rich for an underwear company that is underspending in SG&A. What happens when capacity growth starts to slow in '09, pricing pressure (more WMT exposure) kicks in, GM% erodes, and SG&A growth accelerates to support a new mass-retailer-based business model? We can't imagine that the end result will be anything that could support a 20x+ EBITDA multiple.
© 2021 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.